Petros Pharmaceuticals
PTPI
#11325
Rank
A$0.18 M
Marketcap
A$0.004440
Share price
0.00%
Change (1 day)
-85.50%
Change (1 year)

Earnings for Petros Pharmaceuticals (PTPI)

Earnings in 2026 (TTM): -A$4.71 Million

According to Petros Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$6.67 Million, an increase over its 2024 earnings that were of -A$13.96 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Petros Pharmaceuticals from 2020 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$4.71 Million-29.33%
2025 -A$6.67 Million-52.26%
2024 -A$13.96 Million15.47%
2023 -A$12.09 Million-59.26%
2022 -A$29.66 Million122.97%
2021 -A$13.31 Million-59.18%
2020 -A$32.59 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Nymox Pharmaceutical
NYMX
-A$3.2 Million-32.51% Bahamas
NRC Health
NRC
A$21.88 M-561.88%๐Ÿ‡บ๐Ÿ‡ธ USA